Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Al-Akash SI, Goodship THJ, Smith RJH, Legendre CM, Licht C, Muus P, Bedrosian CL, Fremeaux-Bacchi V, Loirat C

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 54th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Year of Conference: 2012

Pages: abstract no. 2085

ISSN: 0006-4971

Publisher: American Society of Hematology

URL: http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/2085

Library holdings: Search Newcastle University Library for this item

Series Title: Blood

ISBN: 15280020

ePrints